| Financial Year |
March 31 2023 |
| Monetary Funds |
694,101,359.15 |
| Held-for-trading Financial Assets |
708,799,837.20 |
| Notes Receivable |
28,716,622.88 |
| Accounts Receivable |
363,061,036.21 |
| Advances to Suppliers |
46,871,384.89 |
| Other Receivables |
24,976,291.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
777,214,047.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,453,500.00 |
| Other Current Assets |
43,509,625.71 |
| Total Current Assets |
2,768,492,375.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
568,310,000.00 |
| Fixed Assetes |
90,370,186.16 |
| Under-construction Projects |
4,500,076.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,481,057.79 |
| R&D expenses |
-- |
| Goodwill |
731,361,360.91 |
| Long-Term Deferred and Prepaid Expenses |
3,522,847.75 |
| Deferred Income Tax Assets |
10,927,183.35 |
| Other Non-Current Assets |
662,351,834.25 |
| Sub-Total of Non-Current Assets |
2,199,467,779.47 |
| Total Assets |
4,967,960,154.88 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
42,079,493.11 |
| Accounts Payable |
128,861,359.13 |
| Accounts Received In Advance |
6,997,570.72 |
| Employee Compensation Payable |
18,044,189.33 |
| Taxes Payable |
11,362,617.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
299,461,207.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,282,319.91 |
| Other Current Liabilities |
612,858.96 |
| Sub-Total of Current Liabilities |
523,119,427.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
15,360,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
115,166,072.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
173,238,576.59 |
| Total Liabilities |
696,358,004.28 |
| Paid-In Capital(Or Share Stock) |
711,810,799.00 |
| Capital Surplus |
1,011,425,196.07 |
| Surplus Reserve |
312,624,695.71 |
| LESS:Treasury Stock |
67,178,292.94 |
| Undistributed Profits |
2,279,708,657.00 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,271,602,150.60 |
| Owner's Equity（Stockholder's Equity） |
4,271,602,150.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,967,960,154.88 |
